pulmonary-fibrosis

Documents about pulmonary-fibrosis

• Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis#1499563ClinicalTrials.gov
• Cardiovascular Fibrosis in Idiopathic Pulmonary Fibrosis#905022ClinicalTrials.gov
• Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis#1086773ClinicalTrials.gov
• Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis#1196156ClinicalTrials.gov
• Pulmonary Fibrosis Foundation Patient Registry#1228120ClinicalTrials.gov
• Atezolizumab for Idiopathic Pulmonary Fibrosis#1442945ClinicalTrials.gov
• Pulmonary Fibrosis Contact Registry#1378315ClinicalTrials.gov
• Phase 2 Clinical Trial of MNKD-201 (Nintedanib Dry Powder Inhalation) in Patients With Idiopathic Pulmonary Fibrosis#1408148ClinicalTrials.gov
• Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis#850113ClinicalTrials.gov
• TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary Fibrosis#1281534ClinicalTrials.gov
• Study Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary Fibrosis#1074305ClinicalTrials.gov
• A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis#1103446ClinicalTrials.gov
• Exercise Training at Ambulatory Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis Patients#866434ClinicalTrials.gov
• Dyspnea and Idiopathic Pulmonary Fibrosis#1338224ClinicalTrials.gov
• Hereditary Influences on Pulmonary Fibrosis Trajectories#1214706ClinicalTrials.gov
• Investigating Idiopathic Pulmonary Fibrosis in Greece#917308ClinicalTrials.gov
• Detection of Early Idiopathic Pulmonary Fibrosis#1443855ClinicalTrials.gov
• Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension#1370956ClinicalTrials.gov
• Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis#883566ClinicalTrials.gov
• Study on Phenotypic Characterization of Combined Pulmonary Fibrosis and Emphysema#1338978ClinicalTrials.gov
• Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis#900270ClinicalTrials.gov
• The Effectiveness of Pulmonary Rehabilitation on Saturation in Patients With Idiopathic Pulmonary Fibrosis#1477257ClinicalTrials.gov
• Precision Diagnosis and Care for Families With Pulmonary Fibrosis in Ireland#981845ClinicalTrials.gov
• Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF)#888418ClinicalTrials.gov
• A Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF)#1230939ClinicalTrials.gov
• QAX576 in Patients With Pulmonary Fibrosis Secondary to Systemic Sclerosis#1339659ClinicalTrials.gov
• Study of Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis (IPF)#1377781ClinicalTrials.gov
• The Role of Epiregulin in Idiopathic Pulmonary Fibrosis#1236001JLUpub
• Markers of Pulmonary Dysbiosis Associated With Exacerbation in Patients Followed for Cystic Fibrosis#1104195ClinicalTrials.gov
• Idiopathic Pulmonary Fibrosis Job Exposures Study#1151017ClinicalTrials.gov
• Explanted Lung Tissues With Pulmonary Fibrosis#1261665ClinicalTrials.gov
• The Genetics of Pulmonary Fibrosis#1295661ClinicalTrials.gov
• Adherence to Nintedanib Among Idiopathic Pulmonary Fibrosis Patients#1396977ClinicalTrials.gov
• Sarcopenia in Patients With Idiopathic Pulmonary Fibrosis#825037ClinicalTrials.gov
• Allogeneic Human Cells (hMSC)in Patients With Idiopathic Pulmonary Fibrosis Via Intravenous Delivery (AETHER)#1385318ClinicalTrials.gov
• IPF Italian Observational Study (FIBRONET) in Idiopathic Pulmonary Fibrosis#854713ClinicalTrials.gov
• Idiopathic Pulmonary Fibrosis Registry China Study#860173ClinicalTrials.gov
• AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis#1259632ClinicalTrials.gov
• Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)#1228824ClinicalTrials.gov
• Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry#1244078ClinicalTrials.gov
• Open-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)#856303ClinicalTrials.gov
• A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis#1096115ClinicalTrials.gov
• Home-Based Pulmonary Rehab for Patients With Pulmonary Fibrosis#804980ClinicalTrials.gov
• Pulmonary Fibrosis Lung Sounds Study#867688ClinicalTrials.gov
• Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)#877151ClinicalTrials.gov
• Morphine for Dyspnea in Pulmonary Fibrosis#895928ClinicalTrials.gov
• Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical Study#895944ClinicalTrials.gov
• Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis#1057439ClinicalTrials.gov
• Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry#1072831ClinicalTrials.gov
• Oxygen Nanobubble Drink Impact on Exercise in Pulmonary Fibrosis#1463698ClinicalTrials.gov